Tower Research Capital (TRC)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-518
| Closed | -$35K | – | 4868 |
|
|
2019
Q3 | $35K | Buy |
518
+213
| +70% | +$14.6K | ﹤0.01% | 2058 |
|
|
2019
Q2 | $18K | Buy |
+305
| New | +$18.1K | ﹤0.01% | 2261 |
|
|
2019
Q1 | – | Sell |
-115
| Closed | -$7K | – | 4648 |
|
|
2018
Q4 | $7K | Sell |
115
-82
| -42% | -$5.75K | ﹤0.01% | 2754 |
|
|
2018
Q3 | $14K | Buy |
197
+4
| +2% | +$234 | ﹤0.01% | 2585 |
|
|
2018
Q2 | $10K | Buy |
+193
| New | +$7.66K | ﹤0.01% | 2812 |
|
|
2018
Q1 | – | Sell |
-615
| Closed | -$21K | – | 4170 |
|
|
2017
Q4 | $21K | Sell |
615
-2,379
| -79% | -$75.9K | ﹤0.01% | 2051 |
|
|
2017
Q3 | $96K | Buy |
+2,994
| New | +$94.4K | 0.01% | 1409 |
|
|
2017
Q1 | – | Sell |
-907
| Closed | -$27K | – | 4328 |
|
|
2016
Q4 | $27K | Buy |
907
+160
| +21% | +$4.88K | ﹤0.01% | 1897 |
|
|
2016
Q3 | $22K | Buy |
747
+597
| +398% | +$16.6K | ﹤0.01% | 1560 |
|
|
2016
Q2 | $4K | Buy |
+150
| New | +$3.98K | ﹤0.01% | 3593 |
|
|
2016
Q1 | – | Sell |
-356
| Closed | -$13K | – | 5333 |
|
|
2015
Q4 | $13K | Sell |
356
-70
| -16% | -$1.88K | ﹤0.01% | 1836 |
|
|
2015
Q3 | $9K | Sell |
426
-1,270
| -75% | -$32.7K | ﹤0.01% | 2420 |
|
|
2015
Q2 | $47K | Sell |
1,696
-144
| -8% | -$4.06K | ﹤0.01% | 1423 |
|
|
2015
Q1 | $56K | Buy |
1,840
+1,264
| +219% | +$40.2K | 0.01% | 1388 |
|
|
2014
Q4 | $18K | Buy |
576
+16
| +3% | +$521 | ﹤0.01% | 1688 |
|
|
2014
Q3 | $16K | Buy |
560
+460
| +460% | +$12.8K | ﹤0.01% | 2504 |
|
|
2014
Q2 | $3K | Sell |
100
-499
| -83% | -$13.3K | ﹤0.01% | 3273 |
|
|
2014
Q1 | $16K | Buy |
599
+399
| +200% | +$11.4K | ﹤0.01% | 2138 |
|
|
2013
Q4 | $6K | Sell |
200
-105
| -34% | -$3.33K | ﹤0.01% | 3454 |
|
|
2013
Q3 | $9K | Sell |
305
-3,868
| -93% | -$129K | ﹤0.01% | 3304 |
|
|
2013
Q2 | $132K | Buy |
+4,173
| New | +$137K | 0.01% | 400 |
|
Tower Research Capital (TRC)'s GHDX Position: Q4 2019 in Review
Tower Research Capital (TRC) sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 518 shares — an estimated $35K sold.
Tower Research Capital (TRC) first reported a position in GHDX in Q2 2013 and held it in 21 quarters. The position peaked at $132K in Q2 2013. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Tower Research Capital (TRC) reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 518 Genomic Health, Inc. shares in Q4 2019, an estimated $35K.
- Tower Research Capital (TRC) first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 21 quarters.
- Tower Research Capital (TRC)'s Genomic Health, Inc. position peaked at $132K in Q2 2013.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.